Pasithea Therapeutics Corp. (KTTA)
$0.57+$0.01 (+2.45%) Today
Lawrence Steinman - Director
Tiago Marques - OfficerTiago Marques - OfficerLawrence Steinman - DirectorPasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 100,000 | $53K |
19 Form 4 filings on record, the earliest from Oct 27, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Coastlands Capital LP - 10% Owner | Open-market purchase | Common Stock | 100,000 | $0.53 | $53K | |
| Tiago Marques - Officer | Grant or award | Stock Option (right to buy) | 1,756,069 | $0.00 | - | |
| Lawrence Steinman - Director | Grant or award | Stock Option (right to buy) | 152,783 | $0.00 | - | |
| Simon Dumesnil - Director | Grant or award | Stock Option (right to buy) | 152,783 | $0.00 | - | |
| Daniel H. Schneiderman - Officer | Grant or award | Stock Option (right to buy) | 1,129,323 | $0.00 | - | |
 Kartik Krishnan - Officer | Grant or award | Stock Option (right to buy) | 1,129,323 | $0.00 | - | |
| Emer Leahy - Director | Grant or award | Stock Option (right to buy) | 152,783 | $0.00 | - | |
| Alfred J. Novak - Director | Grant or award | Stock Option (right to buy) | 152,783 | $0.00 | - | |
| Lawrence Steinman - Director | Open-market purchase | Common Stock | 133,333 | $0.75 | $100K | |
| Daniel H. Schneiderman - Officer | Grant or award | Common Stock | 26,667 | $0.75 | $20K | |
| Emer Leahy - Director | Grant or award | Common Stock | 33,333 | $0.75 | $25K | |
| Simon Dumesnil - Director | Open-market purchase | Common Stock | 33,333 | $0.75 | $25K | |
| Tiago Marques - Officer | Open-market purchase | Common Stock | 33,333 | $0.75 | $25K | |
| Tiago Marques - Officer | Grant or award | Stock Option (right to buy) | 493,341 | $0.00 | - | |
| Emer Leahy - Director | Grant or award | Stock Option (right to buy) | 42,913 | $0.00 | - | |
| Simon Dumesnil - Director | Grant or award | Stock Option (right to buy) | 42,913 | $0.00 | - | |
| Daniel H. Schneiderman - Officer | Grant or award | Stock Option (right to buy) | 317,266 | $0.00 | - | |
| Alfred J. Novak - Director | Grant or award | Stock Option (right to buy) | 42,913 | $0.00 | - | |
| Lawrence Steinman - Director | Grant or award | Stock Option (right to buy) | 242,913 | $0.00 | - |
Pasithea Therapeutics Corp. (KTTA) had 1 insider filing in the last 90 days, with the most recent on 2026-06-22. The full record for KTTA runs to 19 Form 4 filings, the earliest from 2025-10-27. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
1 insider purchase of KTTA was filed in the last 90 days, totaling $53K.
No insider sales of KTTA were filed in the last 90 days.
This page tracks KTTA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add KTTA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$KTWOK2 Capital Acquisition Corp
$KUSTKUSTOM ENTERTAINMENT, INC.
$KWKennedy-Wilson Holdings, Inc.
$KWMK Wave Media Ltd.
$KYIVKyivstar Group Ltd.
$KYNKayne Anderson Energy Infrastructure Fund, Inc.
$KZIAKAZIA THERAPEUTICS LTD
$LABTLakewood-Amedex Biotherapeutics Inc.
$LAESSEALSQ Corp
$LAFAULaFayette Acquisition Corp.Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.